Enterprise Document Management in Life Sciences
The majority of a life science company's knowledge is resident largely in the form of "unstructured content." Read more.
Assessing Technology-Based Collaboration for Life Sciences
Technology-based collaboration is one of the hottest topics in the life science industry today. But where's the real value? Read more.
Enterprise Contract Management
As the life sciences industry looks in vain for the next blockbuster to boost its finances, a potentially lucrative source of profit and revenue is staring many life sciences firms in the face. Read more.
Utilizing the Right Levers to Make Clinical Trials More Efficient
The latest generation of clinical trials data management systems is paving the way for pharma companies to conduct clinical trials in lower-cost countries while improving decision-making and increasing the quality and transparency of the data. Read more.
PLM Matters More Than Ever
Pharmaceutical companies are missing vital opportunities to maximize their products' lifetime value. Read more.
Meeting Mid-Tier Business Needs
Mid-tier pharma and biotech companies must achieve sustainable growth while maintaining regulatory compliance - the good news is that help is available. Read more.
Business Intelligence Helps Pharmas Work Smarter
A long-standing Holy Grail of IT, business intelligence, is re-emerging as one of the hottest IT topics. Read more.
Truly Mobile - Improving Pharma Sales Force Effectiveness
Investment in mobile technologies is growing at over 50 percent per annum across industries and around the world. It is one of the few clear IT growth areas. Interest from pharma companies is growing fast, too. Read more.
Improving the ROI of Your SAP Implementation
SAP's enterprise solution is ubiquitous - not least in the pharmaceutical industry, where its client list reads like a 'Who's Who' of industry leaders. But for some of these clients, SAP has not been the lifesaver they thought it would be. Read more.
Implementing RFID-Driven Electronic Product Codes Could Save You $100M a Year
Counterfeit products cost the U.S. industry in excess of $1 billion per year, representing as much as $50-$100 million in lost revenue per major pharmaceutical manufacturer. Read more.